Home › Funds › RTW INVESTMENTS, LP › TNGX
RTW INVESTMENTS, LP position in TNGX
TANGO THERAPEUTICS INC · Health Care
RTW INVESTMENTS, LP reported holding 14,048,477 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$350.5M, representing 3.54% of its reported portfolio and ranking #6 among its reported holdings. RTW INVESTMENTS, LP has disclosed TNGX holdings in 5 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How RTW INVESTMENTS, LP's TNGX position evolved
RTW INVESTMENTS, LP first disclosed a stake in TNGX in Q4 2023 at 1,966,752 shares (US$19.5M). The position peaked in Q2 2026 at 13,900,620 shares, worth US$434.5M. Across 5 filings, RTW INVESTMENTS, LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 14,048,477 shares valued at US$350.5M — an increase of 147,857 shares quarter over quarter.. Notable position changes include a 792% increase in Q1 2026 (shares rose 49% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.97M | $19.47M | New |
| Q4 2025 | 1.49M | $13.21M | New |
| Q1 2026 | 13.30M | $278.25M | Add |
| Q2 2026 | 13.90M | $434.53M | Add |
| Q3 2026 | 14.05M | $350.51M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TNGX and 13F data
TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 69 other funds we track also report a position in TNGX — the largest reported positions include Farallon Capital Management (US$383.8M), Boxer Capital Management, LLC (US$340.0M), Paradigm Biocapital Advisors LP (US$173.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TNGX
- Farallon Capital Management 12.28M sh · $383.78M · Q2 2026
- Boxer Capital Management, LLC 10.88M sh · $339.99M · Q2 2026
- Paradigm Biocapital Advisors LP 6.96M sh · $173.69M · Q3 2026
- Siren, L.L.C. 6.78M sh · $169.26M · Q3 2026
- TCG Crossover Management, LLC 6.77M sh · $168.99M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 4.19M sh · $131.00M · Q2 2026
- TRV GP IV, LLC 6.37M sh · $120.18M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 4.55M sh · $113.54M · Q3 2026
- Deep Track Capital, LP 4.50M sh · $112.28M · Q3 2026
- PERCEPTIVE ADVISORS LLC 3.38M sh · $105.57M · Q2 2026
- Seven Fleet Capital Management LP 3.23M sh · $95.66M · Q2 2026
- Caligan Partners LP 2.50M sh · $78.15M · Q2 2026
More on RTW INVESTMENTS, LP
FAQ
How long has RTW INVESTMENTS, LP held TNGX?
RTW INVESTMENTS, LP has disclosed TNGX holdings in 5 of the last 12 reported quarters, going back to Q4 2023.
What is RTW INVESTMENTS, LP's current position in TNGX?
As of Q3 2026, RTW INVESTMENTS, LP holds 14.05M shares of TNGX (TANGO THERAPEUTICS INC), valued at $350.51M, representing 3.54% of its reported portfolio and ranking #6.
Has RTW INVESTMENTS, LP been buying or selling TNGX?
In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP increased its position in TNGX. The position peaked in Q2 2026 at 13.90M shares.
Which other funds hold TNGX?
Other major institutional holders of TNGX include Farallon Capital Management, Boxer Capital Management, LLC, Paradigm Biocapital Advisors LP, among 69 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.